Clinical Trials
6 trialsNCT00617799 2023-10-10
Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
University of Nebraska
Completed
NCT00898183 2018-06-28
S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma
SWOG Cancer Research Network
Completed
NCT00937781 2017-05-17
Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690
Eastern Cooperative Oncology Group
Completed
NCT01209299 2017-05-17
Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate
Eastern Cooperative Oncology Group
Completed
NCT00565968 2015-03-06
Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg
Duke University
Phase 1 Completed
NCT00466687 2013-07-22
Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma
Vanderbilt-Ingram Cancer Center
Phase 2 Completed